The deactivation of two genes could be the cause of Alzheimer'sJune 01, 2004Alzheimer's disease could be caused by the deactivation of what are known as "presenilin genes". Using mice as a model for the study of Alzheimer's in humans, a scientific team headed by the researcher Carlos Saura, from the Universitat Autònoma de Barcelona, has discovered that when these genes mutate and stop working they cause neuro-degeneration and memory loss, giving rise to what in humans would be Alzheimer's. The discovery, published in Neuron, is totally unexpected, since up till now it was thought that the alteration that caused Alzheimer's was exactly the opposite, that is to say, an excess of presenilin activity. Since 1995 it has been known that family hereditary Alzheimer's is caused mainly by mutations in presenilin genes, but it was thought that the alteration of these genes caused Alzheimer's due to an increase in their activity. Research by doctor Carlos Saura, of the Neuroscientific Institute (l'Institut de Neurocie'ncies (IN)) at the Universitat Autònoma de Barcelona, using mice, genetically modified to decrease the activity of presenilin genes, has shown that these genes take part in the process of memory consolidation and neuron survival, but in a different way to that expected. The results, published in the journal Neuron last April, show that the absence of activity of these genes in mice, used as a model for the study of Alzheimer's in humans, causes symptoms very similar to those observed in persons suffering from Alzheimer's: progressive memory loss and neuro-degeneration. The authors suggest that mutations in presenilins could be a cause of Alzheimer's, mainly due to loss of functionality. Besides, in this study the researchers identify the molecular mechanisms by which the deactivation of these genes in the mice's brains leads to memory loss and neuron death. According to this study, the presenilins regulate a group of genes that take part in the process of memory formation. The study suggests that in the first stages of the illness there is a decline in presenilin activity which leads to an imbalance in the cellular processes that control memory and causes neuron death. The discovery opens new avenues for treatment and prevention of Alzheimer's disease, a neuro-degenerative disease that affects 400,000 people in Spain, and without any effective treatment. In the opinion of doctor Carlos Saura "pharmacological treatment that activates the cellular pathways regulated by presenilins could prevent or improve memory loss in patients". | |||||||||||||||||||||
|
Related Alzheimer Disease Current Events and Alzheimer Disease News Articles Vitamin B does not slow cognitive decline in Alzheimer's A clinical trial led by Paul S. Aisen, M.D., professor of neurosciences at the University of California, San Diego School of Medicine, showed that high-dose vitamin B supplements did not slow the rate of cognitive decline in patients with mild to moderate Alzheimer disease. Protecting patient privacy the new fashioned way Protecting patient privacy has been recognized as the duty of health-care providers for about as long as doctors have seen patients. In 1996 that duty became a legal obligation when Congress passed the Health Insurance Portability and Accountability Act. Study confirms benefit of combination therapy for Alzheimer's disease Extended treatment with Alzheimer's disease drugs can significantly slow the rate at which the disorder advances, and combination therapy with two different classes of drugs is even better at helping patients maintain their ability to perform daily activities. Seniors with type 2 diabetes may experience memory declines immediately after eating unhealthy meal Adults with type 2 diabetes who eat unhealthy, high-fat meals may experience memory declines immediately afterward, but this can be offset by taking antioxidant vitamins with the meal, according to new research from Baycrest. Memory loss linked to common sleep disorder For the first time, UCLA researchers have discovered that people with sleep apnea show tissue loss in brain regions that help store memory. Strong associations between disturbed rest/activity rhythms and mortality rates in older men A research abstract that will be presented on Wednesday at SLEEP 2008, the 22nd Annual Meeting of the Associated Professional Sleep Societies (APSS), is the first to report strong associations between disturbed rest/activity rhythms and mortality rates in older, community-dwelling (non-institutionalized) men. Hopkins researchers discover new link to schizophrenia Neuroscientists at Johns Hopkins have discovered that mice lacking an enzyme that contributes to Alzheimer disease exhibit a number of schizophrenia-like behaviors. A significant difference in the sleep disturbances among Alzheimer patients, caregivers A study published in the May 1 issue of the journal SLEEP finds that sleep disturbances among Alzheimer patients vary significantly from those of their family caregivers, and that, surprisingly, poor sleep in either the patient or caregiver is not necessarily linked to disturbed sleep in the other. Alzheimer's vaccine clears plaque but has little effect on learning and memory impairment A promising vaccine being tested for Alzheimer's disease does what it is designed to do - clear beta-amyloid plaques from the brain - but it does not seem to help restore lost learning and memory abilities, according to a University of California, Irvine study. Why fish oil is good for you It's good news that we are living longer, but bad news that the longer we live, the better our odds of developing late-onset Alzheimer's disease. More Alzheimer Disease Current Events and Alzheimer Disease News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||